- £12.97bn
- £14.82bn
- £5.49bn
- 93
- 33
- 99
- 91
2020 January 25th | 2021 January 30th | 2022 January 29th | 2023 January 28th | 2024 January 27th | |
---|---|---|---|---|---|
Period Length: | 52 W | 53 W | 52 W | 52 W | 52 W |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,266 | 3,534 | 4,626 | 5,034 | 5,491 |
Cost of Revenue | |||||
Gross Profit | 1,682 | 1,303 | 2,001 | 2,206 | 2,457 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,412 | 3,090 | 3,721 | 4,093 | 4,395 |
Operating Profit | 854 | 445 | 905 | 942 | 1,097 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 749 | 342 | 823 | 869 | 1,016 |
Provision for Income Taxes | |||||
Net Income After Taxes | 610 | 287 | 678 | 711 | 801 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 610 | 287 | 678 | 712 | 802 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 610 | 287 | 678 | 712 | 802 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.46 | 3.3 | 5.84 | 6.96 | 6.66 |
Dividends per Share | |||||
Special Dividends per Share |